# Atrantil for Intestinal Bacterial Overgrowth

> **NCT04755673** · NA · COMPLETED · sponsor: **Northwestern University** · enrollment: 40 (actual)

## Conditions studied

- Irritable Bowel Syndrome
- Bacterial Overgrowth Syndrome
- SIBO

## Interventions

- **OTHER:** Atrantil (Medical Food)

## Key facts

- **NCT ID:** NCT04755673
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-18
- **Primary completion:** 2022-09-26
- **Final completion:** 2022-09-27
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04755673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04755673, "Atrantil for Intestinal Bacterial Overgrowth". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04755673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*